Document Detail


A randomised prospective comparison of oral ofloxacin and intraperitoneal vancomycin plus aztreonam in the treatment of bacterial peritonitis complicating continuous ambulatory peritoneal dialysis (CAPD).
MedLine Citation:
PMID:  2049419     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Forty six patients who developed 48 episodes of peritonitis while on CAPD were randomised to receive either oral ofloxacin or intraperitoneal (i.p.) vancomycin/aztreonam. Three patients were excluded from analysis: 2 were transferred to other hospitals and 1 was later found to have candida peritonitis. Of the remainder, 22 episodes were treated with oral ofloxacin and 23 with i.p. vancomycin/aztreonam. The primary cure rate in the oral ofloxacin and i.p. vancomycin/aztreonam group was 77.3% and 87.5% respectively. There were 3 primary failures and 2 relapses in the former and 1 failure and 2 relapses in the latter group. Two of the 4 primary failures were peritonitis episodes secondary to infection with pseudomonas species. The total number of days of hospital stay was 48 and 58 respectively in the two groups. Analysis of the cost of treatment revealed that i.p. vancomycin/aztreonam was 30 times more expensive than oral ofloxacin. Despite a slightly higher cure rate with i.p. vancomycin/aztreonam, oral ofloxacin is a more cost-effective primary treatment of bacterial peritonitis in patients on CAPD especially in countries with a limited health budget.
Authors:
I K Cheng; C Y Chan; W T Wong
Related Documents :
11774109 - Evaluation of doqi guidelines: early start of dialysis treatment is not associated with...
18264929 - Lessons for dialysis investigators from the steno-2 study.
11587399 - Trends in capd technique failure: canada, 1981-1997.
18583749 - Once weekly low dose subcutaneous erythropoietin: an economic solution for the manageme...
19579619 - High sensitivity c-reactive protein in spontaneous bacterial peritonitis with nonneutro...
12800379 - Auditory brainstem response in children with iron deficiency anemia.
17957379 - Enlargement of the hypofluorescent post photodynamic therapy treatment spot after a com...
19358199 - Management of oral feeding in children undergoing airway reconstruction.
22340549 - Safety and feasibility of repeated percutaneous transradial coronary intervention in th...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis     Volume:  11     ISSN:  0896-8608     ISO Abbreviation:  Perit Dial Int     Publication Date:  1991  
Date Detail:
Created Date:  1991-07-22     Completed Date:  1991-07-22     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8904033     Medline TA:  Perit Dial Int     Country:  CANADA    
Other Details:
Languages:  eng     Pagination:  27-30     Citation Subset:  IM    
Affiliation:
Department of Medicine, University of Hong Kong, Queen Mary Hospital.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Oral
Aztreonam / administration & dosage
Bacterial Infections / drug therapy*
Drug Therapy, Combination / therapeutic use*
Humans
Ofloxacin / administration & dosage,  therapeutic use*
Peritoneal Dialysis, Continuous Ambulatory / adverse effects*
Peritonitis / drug therapy*,  microbiology
Vancomycin / administration & dosage
Chemical
Reg. No./Substance:
1404-90-6/Vancomycin; 78110-38-0/Aztreonam; 82419-36-1/Ofloxacin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The mesothelial cells in CAPD effluent and their relation to peritonitis incidence.
Next Document:  Initial treatment of dialysis associated peritonitis: a controlled trial of vancomycin versus cefazo...